MGH Interventional Cardiology Research
@MGH_IC_Research
Followers
644
Following
73
Media
1
Statuses
85
MGH's Interventional Cardiology Research Program focuses on delivering innovative catheter-based techniques to diagnose and treat in all areas of IC.
Massachusetts General Hospital
Joined February 2021
Final graduating fellows CGR presentation ended season on a very high note: from dyslipidemia genetics to AS progression and STEMI care in Kenya. Truly impressive breadth and depth - and all headed for intervention. The future is bright! @ddefariayeh @md_harrington @JKhambhati
2
13
64
@MGH_IC_Research @UCSFCardiology It has been a privilege working with my amazing team at @MGH_IC_Research! Will miss you all tremendously!
3
1
8
Congratulations @SammyElmariahMD, We are so proud of you!
Welcome @SammyElmariahMD! Starting in Sept as Chief of Interventional Cardiology & Med Dir Cath Lab. Dr Elmariah is an expert in structural heart disease interventions & catheter-based valve therapies. He has an NIH-funded research program & is a leader in valve treatment trials.
0
0
3
We are saying goodbye to our Program Director @SammyElmariahMD who will be moving on to Chief of Interventional Cardiology & Med Dir Cath Lab at @UCSFCardiology. We are so honored to have been led by someone with such an immense passion for research. Congrats & we will miss you!
2
2
36
*NEW* in @JAHA_AHA. How much will your patient improve after CTO PCI? We developed the OPEN-AP score (calculator available at https://t.co/Jj2aTVT2Aw) to help clinicians identify patients most likely to benefit from #PCI of a #CTO lesion. #CTO101
https://t.co/Q5P8GBLYQx 1/5
5
17
75
#20YearsOfTAVR - Impact of Decision Aid on Decision-making of Patients w Severe Aortic Stenosis: Randomized Pilot Study #ACC #AVR #TAVR #SAVR
https://t.co/fp89ksCDfU
0
3
5
Fantastic talk by @RatickM on impact of lead extraction on TR severity at #ACC22. @MGH_IC_Research @MGHHeartHealth
1
3
30
We're greatful and excited as we continue our involvement in both the TRISCEND EFS and TRISCEND II Trials under the direction of MGH site PI @SammyElmariahMD *view our website for more information on these research trials:
massgeneral.org
Our valve research program focuses on the treatment of aortic, mitral and tricuspid valve disease by replacing or repairing valves in a variety of ways.
0
1
2
Early experience with the transfemoral EVOQUE system in patients with clinically significant TR demonstrated technical feasibility, acceptable safety, TR reduction, and symptomatic improvement at 30 days. https://t.co/oW4N2NX25l
@SammyElmariahMD & Ignacio Inglessis, MD
pubmed.ncbi.nlm.nih.gov
Early experience with the transfemoral EVOQUE system in patients with clinically significant TR demonstrated technical feasibility, acceptable safety, TR reduction, and symptomatic improvement at 30...
1
1
3
PCI among anticoagulated patients: Potential opportunity for CYP2C19 genotyping to optimize bleeding/ischemic risks discussed by @DimitriMaamari @FaroucJaffer @amitvkhera @aklfahed cc @MGH_IC_Research @MGHHeartHealth @CircAHA @GenPrecisionMed
In patients on anticoagulation, aspirin is discontinued as soon as few days after PCI, continuing OAC+clopidogrel. BUT up to 15% of people are poor metabolizers of clopidogrel. Should CYP2C19 genotyping be routine? We discuss in @CircAHA
https://t.co/p953cqHuy5
0
5
12
@DrDarshanDoshi presenting the Literature Year in Review at CTO Plus 2022 - was a busy year! #CTO2022 @MGHHeartHealth @MGH_IC_Research
0
3
35
Over an 18-year period, the proportion of patients with an indication for AVR who did not receive AVR has remained substantial despite the rapid growth of AVR volumes. Great collaboration from IC PIs @SammyElmariahMD @NilayPatelMD and Ignacio Inglessis, MD https://t.co/xaddXVPnBe
0
4
12
@MGH_IC_Research @rwyeh I was privileged to be trained by IK 2013 - 2015. His commitment to scientific research is extraordinary and he is also an excellent and beloved clinical instructor in the Cath lab. Congrats and certainly well deserved!
0
1
3
Congratulations IK!! A tour de force and remarkable career illuminating coronary pathobiology through intracoronary optical coherence tomography #OCT @MGHHeartHealth
Congratulations to IC PI, Ik-Kyung Jang, MD, for being awarded the 2022 Distinguished Scientist Award by the American College of Cardiology in recognition of the major scientific contributions to the advancement of scientific knowledge in the field of cardiovascular disease.
0
3
24
Congratulations to IC PI, Ik-Kyung Jang, MD, for being awarded the 2022 Distinguished Scientist Award by the American College of Cardiology in recognition of the major scientific contributions to the advancement of scientific knowledge in the field of cardiovascular disease.
2
16
115
It's only a letter to the editor, (and it's behind a pay-wall), but still, very nice, and on a topic that is so central to what we all do @SVM_tweets. Thank you @docmrjaff @DrJeffreyWOlin1
https://t.co/7nwNZIlUHy
@NEJM
1
4
23
IVUS-guidance during PCI saves lives Analysis of pooled data from 2 trials (ULTIMATE and IVUS-XPL) for long stents >=28mm, shows 57% improvement in cardiac death within 3 years. https://t.co/7GRTuFN11O
0
35
123
@noshreza @ACCinTouch @MinnowWalsh @pamelasdouglas @TYWangMD @EldrinL @ShashankSinhaMD @DrLaPrincess @Drroxmehran @aayshacader @AAgarwalaMD @EstefaniaOS @DrBenzigerHeart @krishnapatel888 @malamo512 @ngilotraMD @DhariniRamu @YevgeniyBr @ZainAsadEP Wonderful to be here! Thank you @rosenzweig_a @MGH_IC_Research for the support! The #ACCCTR2022 program is invigorating and inspiring - look forward to meeting other attendees in person, what a diverse, skilled and passionate group @ACCinTouch!
0
1
9
"Peripheral Artery Disease in 2022 and Beyond" See our Medical Grand Rounds from IC PI Ido Weinberg, MD @Angiologist & @MGHHeartHealth 's @AnahitaDua
@MassGeneralAiM @MassGeneralNews
https://t.co/cplIqENQwE
advances.massgeneral.org
Anahita Dua, MD, MSc, MBA, director of the Vascular Lab at Massachusetts General Hospital, and Ido Weinberg, MD, medical director of VasCore, presented on peripheral artery disease.
0
0
0